Effects of the dose-volume relationship on and risk factors for maxillary osteoradionecrosis after carbon ion radiotherapy
- PMID: 24708583
- PMCID: PMC3992144
- DOI: 10.1186/1748-717X-9-92
Effects of the dose-volume relationship on and risk factors for maxillary osteoradionecrosis after carbon ion radiotherapy
Abstract
Background: Osteoradionecrosis (ORN) is a critical complication after carbon ion (C-ion) or photon radiotherapy (RT) for head and neck tumors. However, the risk factors for ORN after C-ion RT remain unclear. Therefore, the present study aimed to investigate the effects of the dose-volume relationship on and risk factors for ORN development after C-ion RT. We, however, focused on the maxillary bone because most tumors treated with C-ion RT were primarily located in the sinonasal cavity.
Methods: The patients enrolled in this study received more than 10% of the prescribed total dose of 57.6 Gy equivalent (GyE) in 16 fractions to their maxilla. All patients were followed up for more than 2 years after C-ion RT. Those with tumor invasion to the maxilla before C-ion RT or local recurrence after the treatment were excluded from the study to accurately evaluate the effects of irradiation on the bone. Sixty-three patients were finally selected. The severity of ORN was assessed according to the Common Terminology Criteria for Adverse Events version 4.0. The correlation between clinical and dosimetric parameters and ORN incidence was retrospectively analyzed.
Results: The median follow-up period was 79 months. Of the 63 enrolled patients, 26 developed ORN of grade ≥1. Multivariate analysis revealed that the maxilla volume receiving more than 50 GyE (V50) and the presence of teeth within the planning target volume were significant risk factors for ORN. Dose-volume histogram analysis revealed that V10 to V50 parameters were significantly higher in patients with ORN than in those without ORN.
Conclusions: V50 and the presence of teeth within the planning target volume were independent risk factors for the development of ORN after C-ion RT using a 16-fraction protocol.
Figures
Similar articles
-
Clinical features and dosimetric evaluation of carbon ion radiation-induced osteoradionecrosis of mandible in head and neck tumors.Radiother Oncol. 2021 Aug;161:205-210. doi: 10.1016/j.radonc.2021.06.022. Epub 2021 Jun 18. Radiother Oncol. 2021. PMID: 34147522
-
Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.Acta Oncol. 2019 Oct;58(10):1373-1377. doi: 10.1080/0284186X.2019.1643037. Epub 2019 Jul 31. Acta Oncol. 2019. PMID: 31364903
-
Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy's and St Thomas' Head and Neck Cancer Unit experience.Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Jul;122(1):28-34. doi: 10.1016/j.oooo.2016.01.007. Epub 2016 Jan 14. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016. PMID: 27039003
-
[Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers].Cancer Radiother. 2021 Jul;25(5):484-493. doi: 10.1016/j.canrad.2021.03.002. Epub 2021 Apr 6. Cancer Radiother. 2021. PMID: 33836955 Review. French.
-
Timing of dental extractions in patients undergoing radiotherapy and the incidence of osteoradionecrosis: a systematic review and meta-analysis.Br J Oral Maxillofac Surg. 2021 Jun;59(5):511-523. doi: 10.1016/j.bjoms.2020.10.006. Epub 2020 Oct 20. Br J Oral Maxillofac Surg. 2021. PMID: 33685773 Review.
Cited by
-
Clinical significance of adjuvant therapy after radical surgery for primary osteosarcoma of the jaws.Wien Klin Wochenschr. 2023 Sep;135(17-18):488-495. doi: 10.1007/s00508-023-02228-x. Epub 2023 Jun 12. Wien Klin Wochenschr. 2023. PMID: 37308792
-
Dose-volume constraints for head-and-neck cancer in carbon ion radiotherapy: A literature review.Cancer Med. 2023 Apr;12(7):8267-8277. doi: 10.1002/cam4.5641. Epub 2023 Feb 17. Cancer Med. 2023. PMID: 36799088 Free PMC article. Review.
-
A Custom Mouthpiece With Lip Bumper for Osteoradionecrosis Risk Reduction After Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Lip.Adv Radiat Oncol. 2022 Oct 22;8(1):101114. doi: 10.1016/j.adro.2022.101114. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36471821 Free PMC article. No abstract available.
-
Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy.Front Oncol. 2022 Mar 2;12:829502. doi: 10.3389/fonc.2022.829502. eCollection 2022. Front Oncol. 2022. PMID: 35311095 Free PMC article.
-
Carbon-ion radiotherapy in osteosarcoma of the mandible: a case report.J Korean Assoc Oral Maxillofac Surg. 2021 Aug 31;47(4):315-320. doi: 10.5125/jkaoms.2021.47.4.315. J Korean Assoc Oral Maxillofac Surg. 2021. PMID: 34462388 Free PMC article.
References
-
- Mizoe JE, Hasegawa A, Jingu K, Takagi R, Bessyo H, Morikawa T, Tonoki M, Tsuji H, Kamada T, Tsujii H, Okamoto Y. Organizing Committee for the Working Group for Head Neck Cancer. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol. 2012;103:32–37. doi: 10.1016/j.radonc.2011.12.013. - DOI - PubMed
-
- Ben-David MA, Diamante M, Radawski JD, Vineberg KA, Stroup C, Murdoch-Kinch CA, Zwetchkenbaum SR, Eisbruch A. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007;68:396–402. doi: 10.1016/j.ijrobp.2006.11.059. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
